2024-11-012025-10-312025-10-31falseSC678852HC HEALTHCARE SCOTLAND LIMITED2026-05-14falseiso4217:GBPxbrli:pureSC6788522024-10-31SC6788522025-10-31SC6788522024-11-012025-10-31SC6788522023-10-31SC6788522024-10-31SC6788522023-11-012024-10-31SC678852bus:SmallEntities2024-11-012025-10-31SC678852bus:AuditExempt-NoAccountantsReport2024-11-012025-10-31SC678852bus:FullAccounts2024-11-012025-10-31SC678852bus:PrivateLimitedCompanyLtd2024-11-012025-10-31SC678852core:WithinOneYear2025-10-31SC678852core:AfterOneYear2025-10-31SC678852core:WithinOneYear2024-10-31SC678852core:AfterOneYear2024-10-31SC678852core:ShareCapital2025-10-31SC678852core:SharePremium2025-10-31SC678852core:RevaluationReserve2025-10-31SC678852core:OtherReservesSubtotal2025-10-31SC678852core:RetainedEarningsAccumulatedLosses2025-10-31SC678852core:ShareCapital2024-10-31SC678852core:SharePremium2024-10-31SC678852core:RevaluationReserve2024-10-31SC678852core:OtherReservesSubtotal2024-10-31SC678852core:RetainedEarningsAccumulatedLosses2024-10-31SC678852core:LandBuildings2025-10-31SC678852core:PlantMachinery2025-10-31SC678852core:Vehicles2025-10-31SC678852core:FurnitureFittings2025-10-31SC678852core:OfficeEquipment2025-10-31SC678852core:NetGoodwill2025-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2025-10-31SC678852core:ListedExchangeTraded2025-10-31SC678852core:UnlistedNon-exchangeTraded2025-10-31SC678852core:LandBuildings2024-10-31SC678852core:PlantMachinery2024-10-31SC678852core:Vehicles2024-10-31SC678852core:FurnitureFittings2024-10-31SC678852core:OfficeEquipment2024-10-31SC678852core:NetGoodwill2024-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2024-10-31SC678852core:ListedExchangeTraded2024-10-31SC678852core:UnlistedNon-exchangeTraded2024-10-31SC678852core:LandBuildings2024-11-012025-10-31SC678852core:PlantMachinery2024-11-012025-10-31SC678852core:Vehicles2024-11-012025-10-31SC678852core:FurnitureFittings2024-11-012025-10-31SC678852core:OfficeEquipment2024-11-012025-10-31SC678852core:NetGoodwill2024-11-012025-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-31SC678852core:ListedExchangeTraded2024-11-012025-10-31SC678852core:UnlistedNon-exchangeTraded2024-11-012025-10-31SC678852core:MoreThanFiveYears2024-11-012025-10-31SC678852core:Non-currentFinancialInstruments2025-10-31SC678852core:Non-currentFinancialInstruments2024-10-31SC678852dpl:CostSales2024-11-012025-10-31SC678852dpl:DistributionCosts2024-11-012025-10-31SC678852core:LandBuildings2024-11-012025-10-31SC678852core:PlantMachinery2024-11-012025-10-31SC678852core:Vehicles2024-11-012025-10-31SC678852core:FurnitureFittings2024-11-012025-10-31SC678852core:OfficeEquipment2024-11-012025-10-31SC678852dpl:AdministrativeExpenses2024-11-012025-10-31SC678852core:NetGoodwill2024-11-012025-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-31SC678852dpl:GroupUndertakings2024-11-012025-10-31SC678852dpl:ParticipatingInterests2024-11-012025-10-31SC678852dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-31SC678852core:ListedExchangeTraded2024-11-012025-10-31SC678852dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-31SC678852core:UnlistedNon-exchangeTraded2024-11-012025-10-31SC678852dpl:CostSales2023-11-012024-10-31SC678852dpl:DistributionCosts2023-11-012024-10-31SC678852core:LandBuildings2023-11-012024-10-31SC678852core:PlantMachinery2023-11-012024-10-31SC678852core:Vehicles2023-11-012024-10-31SC678852core:FurnitureFittings2023-11-012024-10-31SC678852core:OfficeEquipment2023-11-012024-10-31SC678852dpl:AdministrativeExpenses2023-11-012024-10-31SC678852core:NetGoodwill2023-11-012024-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-31SC678852dpl:GroupUndertakings2023-11-012024-10-31SC678852dpl:ParticipatingInterests2023-11-012024-10-31SC678852dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-31SC678852core:ListedExchangeTraded2023-11-012024-10-31SC678852dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-31SC678852core:UnlistedNon-exchangeTraded2023-11-012024-10-31SC678852core:NetGoodwill2025-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2025-10-31SC678852core:LandBuildings2025-10-31SC678852core:PlantMachinery2025-10-31SC678852core:Vehicles2025-10-31SC678852core:FurnitureFittings2025-10-31SC678852core:OfficeEquipment2025-10-31SC678852core:AfterOneYear2025-10-31SC678852core:WithinOneYear2025-10-31SC678852core:ListedExchangeTraded2025-10-31SC678852core:UnlistedNon-exchangeTraded2025-10-31SC678852core:ShareCapital2025-10-31SC678852core:SharePremium2025-10-31SC678852core:RevaluationReserve2025-10-31SC678852core:OtherReservesSubtotal2025-10-31SC678852core:RetainedEarningsAccumulatedLosses2025-10-31SC678852core:NetGoodwill2024-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2024-10-31SC678852core:LandBuildings2024-10-31SC678852core:PlantMachinery2024-10-31SC678852core:Vehicles2024-10-31SC678852core:FurnitureFittings2024-10-31SC678852core:OfficeEquipment2024-10-31SC678852core:AfterOneYear2024-10-31SC678852core:WithinOneYear2024-10-31SC678852core:ListedExchangeTraded2024-10-31SC678852core:UnlistedNon-exchangeTraded2024-10-31SC678852core:ShareCapital2024-10-31SC678852core:SharePremium2024-10-31SC678852core:RevaluationReserve2024-10-31SC678852core:OtherReservesSubtotal2024-10-31SC678852core:RetainedEarningsAccumulatedLosses2024-10-31SC678852core:NetGoodwill2023-10-31SC678852core:IntangibleAssetsOtherThanGoodwill2023-10-31SC678852core:LandBuildings2023-10-31SC678852core:PlantMachinery2023-10-31SC678852core:Vehicles2023-10-31SC678852core:FurnitureFittings2023-10-31SC678852core:OfficeEquipment2023-10-31SC678852core:AfterOneYear2023-10-31SC678852core:WithinOneYear2023-10-31SC678852core:ListedExchangeTraded2023-10-31SC678852core:UnlistedNon-exchangeTraded2023-10-31SC678852core:ShareCapital2023-10-31SC678852core:SharePremium2023-10-31SC678852core:RevaluationReserve2023-10-31SC678852core:OtherReservesSubtotal2023-10-31SC678852core:RetainedEarningsAccumulatedLosses2023-10-31SC678852core:AfterOneYear2024-11-012025-10-31SC678852core:WithinOneYear2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC678852core:Non-currentFinancialInstrumentscore:CostValuation2025-10-31SC678852core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-31SC678852core:Non-currentFinancialInstrumentscore:CostValuation2024-10-31SC678852core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-31SC678852core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-31SC678852bus:Director12024-11-012025-10-31SC678852bus:Director22024-11-012025-10-31SC678852bus:Director32024-11-012025-10-31SC6788521bus:Director12024-10-31SC6788521bus:Director12024-11-012025-10-31SC6788521bus:Director12025-10-31SC6788522024-10-31SC6788522024-11-012025-10-31SC6788522025-10-31

HC HEALTHCARE SCOTLAND LIMITED

Registered Number
SC678852
(Scotland)

Unaudited Financial Statements for the Year ended
31 October 2025

HC HEALTHCARE SCOTLAND LIMITED
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

CLARK, Christine
CLARK, Harry Shaw Thomas
CLARK, Kevin Thomas

Registered Address

7-8 Alberta Place
East Kilbride
Glasgow
G75 8AA

Registered Number

SC678852 (Scotland)
HC HEALTHCARE SCOTLAND LIMITED
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors3161,98940,772
Cash at bank and on hand32,222-
194,21140,772
Creditors amounts falling due within one year4(56,694)(40,271)
Net current assets (liabilities)137,517501
Total assets less current liabilities137,517501
Net assets137,517501
Capital and reserves
Called up share capital100100
Profit and loss account137,417401
Shareholders' funds137,517501
The financial statements were approved and authorised for issue by the Board of Directors on 14 May 2026, and are signed on its behalf by:
CLARK, Christine
Director
CLARK, Harry Shaw Thomas
Director
CLARK, Kevin Thomas
Director

Registered Company No. SC678852
HC HEALTHCARE SCOTLAND LIMITED
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion at the balance sheet date.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year11
3.Debtors: amounts due within one year

2025

2024

££
Amounts owed by associates and joint ventures / participating interests108,46140,772
Other debtors53,528-
Total161,98940,772
4.Creditors: amounts due within one year

2025

2024

££
Taxation and social security53,1547,131
Other creditors-30,960
Accrued liabilities and deferred income3,5402,180
Total56,69440,271
5.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
CLARK, Christine40,77267,6890108,461
40,77267,6890108,461